Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
05/04/2006 | US20060093612 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
05/04/2006 | US20060093604 Method of treatment and prophylaxis |
05/04/2006 | US20060093603 ErbB4 antagonists |
05/04/2006 | US20060093602 Inflammatory mediator antagonists |
05/04/2006 | US20060093598 Stabilized liquid polypeptide-containing pharmaceutical compositions |
05/04/2006 | US20060093595 Methods, compositions and kits for treating damage to excitable tissue |
05/04/2006 | US20060093585 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
05/04/2006 | US20060093576 Stabilized liquid polypeptide-containing pharmaceutical compositions |
05/04/2006 | US20060093575 Oxaliplatin anti-resistance agent |
05/04/2006 | US20060093567 Method of inhibiting hair growth |
05/04/2006 | US20060093553 Cd26-based therapies for cancers and immune disease |
05/04/2006 | DE19916208B4 Sonnenschutzmittel Sunscreens |
05/04/2006 | DE10320602B4 Verfahren zur Identifizierung einer möglichen Modifikation von mindestens einem biologischen Parameter unter Verwendung von jungen und alten lebenden Zellen A method for identifying a possible modification of at least one biological parameters using young and old living cells |
05/04/2006 | DE102004053023A1 Pharmaceutical formulation useful for treating inflammatory and obstructive respiratory diseases comprises at least one anticholinergic compound, at least one corticosteroid and at least one betamimetic |
05/04/2006 | DE102004052987A1 Composition, useful for treatment of e.g. inflammatory and obstructive respiratory complaint, sinus rhythm in heart in atrioventricular block and circulatory shock, comprises 6-hydroxy-4H-benzo1,4oxazin-3-one derivatives and other actives |
05/04/2006 | DE102004052697A1 Pharmazeutische Zubereitungen zur Behandlung von Folgen des Alkoholmissbrauchs, Hepatitis, Pankreatitis, Alzheimererkrankung, Morbus Parkinson, Diabetes, toxischen Nierenerkrankungen, Reperfusionsschäden, der Arteriosklerose sowie als Antidote gegen Umweltgifte und Medikamentenintoxikation Pharmaceutical preparations for the treatment of episodes of alcohol abuse, hepatitis, pancreatitis, Alzheimer's disease, Parkinson's disease, diabetes, toxic kidney disease, reperfusion injury, atherosclerosis and as antidotes against environmental toxins and prescription drug intoxication |
05/04/2006 | DE102004052167A1 Use of a single substance or combination of one or more substances from the menstrual blood (i.e. the fluid discharged from the vagina that is not controlled/prevented by e.g. tampon) to increase the virility of men and women |
05/04/2006 | CA2587026A1 Use of dipyridamole in combination with antithrombotics for treatment and prevention of thromboembolic diseases |
05/04/2006 | CA2586738A1 (2-carboxamido)(3-amino) thiophene compounds |
05/04/2006 | CA2585977A1 Remedy for endometriosis |
05/04/2006 | CA2585638A1 Aminopyridine derivatives having aurora a selective inhibitory action |
05/04/2006 | CA2583677A1 Tnf-like weak inducer of apoptosis (tweak) receptor binding domain |
05/04/2006 | CA2583446A1 Method of using adapalene in acne maintenance therapy |
05/03/2006 | EP1652539A1 Method of manufacturing a stent comprising an anti-angiogenic composition |
05/03/2006 | EP1652533A1 HEART-SLOWING DRUG CONTAINING SHORT-ACTING &bgr; BLOCKER AS THE ACTIVE INGREDIENT |
05/03/2006 | EP1652532A1 Medicinal composition |
05/03/2006 | EP1652514A1 At-use dispersed preparation |
05/03/2006 | EP1651599A1 Tyrosine kinase inhibitors |
05/03/2006 | EP1651287A2 Injectable composite for the magnetocytolysis of bone metastatic cells |
05/03/2006 | EP1651271A2 Compositions and methods for treating coronavirus infection and sars |
05/03/2006 | EP1651270A1 Medicaments for inhalation comprising betamimetics and an anticholinergic |
05/03/2006 | EP1651259A2 Methods and compositions for producing antigenic responses |
05/03/2006 | EP1651246A2 Method for promoting bone growth |
05/03/2006 | EP1651237A2 Methods for treatment of dermatological conditions |
05/03/2006 | EP1651234A1 Combination of mglur2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders |
05/03/2006 | EP1651224A1 Medicaments for inhalation comprising anticholinergics and a betamimetic |
05/03/2006 | EP1651222A1 Medicaments comprising pde iv inhibitors and an anticholinergic for treating respiratory disorders |
05/03/2006 | EP1651213A1 Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
05/03/2006 | EP1651211A2 Combination of drugs for the treatment of neoplasms |
05/03/2006 | EP1651208A1 Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders |
05/03/2006 | EP1651205A1 Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
05/03/2006 | EP1651204A1 Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator |
05/03/2006 | EP1651194A1 Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin |
05/03/2006 | EP1651176A2 Antimicrobial compositons containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof |
05/03/2006 | EP1651168A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
05/03/2006 | EP1651167A2 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
05/03/2006 | EP1651061A1 Supplement preparation |
05/03/2006 | EP1576150A4 Methods and compositions for increasing the efficacy of biologically-active ingredients |
05/03/2006 | EP1545497A4 Nutritional supplement for children |
05/03/2006 | EP1545496A4 Nutritional supplement for adolescents |
05/03/2006 | EP1528923B1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |
05/03/2006 | EP1490049B1 Citalopram for the treatment of elevated blood pressure |
05/03/2006 | EP1444200B1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1 |
05/03/2006 | EP1427724B1 Novel use of substituted aminomethyl chromans |
05/03/2006 | EP1389129A4 Methods of treating respiratory conditions |
05/03/2006 | EP1368381B1 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
05/03/2006 | EP1368006B1 Novel modified released formulation |
05/03/2006 | EP1363618B1 Pharmaceutical composition for treating multiple sclerosis |
05/03/2006 | EP1336407B1 Composition containing an angiotensin ii receptor antagonist and a diuretic and its use for the treatment of hypertension |
05/03/2006 | EP1313422A4 Non-hormonal vaginal contraceptive |
05/03/2006 | EP1289383B1 Primary composition containing a lipophilic bioactive compound |
05/03/2006 | EP1242060B1 Treatment of metastatic disease |
05/03/2006 | EP1240822B1 Diabetes onset model mammal |
05/03/2006 | EP1236044B1 Diagnosing and treating arthritic disorders |
05/03/2006 | EP1225809B1 Methods for stabilizing liquid nutritional products and products so stabilized |
05/03/2006 | EP1218023B8 Method for calming human beings using personal care compositions |
05/03/2006 | EP1194404B1 Inhibitors of aspartyl protease |
05/03/2006 | EP1189611B1 Cancer therapy |
05/03/2006 | EP1143976B1 Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine for use in the treatment of hiv infections |
05/03/2006 | EP1126863B1 Vascular endothelial growth factor-like protein from orf virus nz10 binds and activates mammalian vegf receptor-2 |
05/03/2006 | EP0955995B1 Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions |
05/03/2006 | EP0901368B1 Dermal penetration enhancers and drug delivery systems involving same |
05/03/2006 | EP0810884B1 Treatment of vascular restenosis with inhaled nitric oxide |
05/03/2006 | EP0793500B1 Pharmaceutical compositions comprising nitric oxide-releasing polysaccharides |
05/03/2006 | CN1767855A Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist |
05/03/2006 | CN1767832A Combinations comprising anti-epileptic drugs for the treatment of neurological disorders. |
05/03/2006 | CN1767831A Pharmaceutical formulations containing methylnaltrexone |
05/03/2006 | CN1767830A The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome |
05/03/2006 | CN1767822A Compositions and method for treating microbial and parasitic infections in cattle and other animals |
05/03/2006 | CN1767819A Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol |
05/03/2006 | CN1765362A Composition containing amlodipine and angiotensin II receptor inhibitor |
05/03/2006 | CN1765351A Method for adjusting human skeleton muscle balance |
05/03/2006 | CN1254541C Novel compound |
05/03/2006 | CN1254272C Activation and inhibition of immune system |
05/03/2006 | CN1254191C Process and composition for controlling fecal hair excretion and trichobezoar formation |
05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
05/02/2006 | US7038015 Interferon gamma polypeptide variants |
05/02/2006 | US7038013 Nucleotide sequences coding polypeptide for use in treatment of immune respone defects |
05/02/2006 | US7037928 Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
05/02/2006 | US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
05/02/2006 | US7037921 Compounds and methods for inhibiting MRP1 |
05/02/2006 | US7037902 Substituted triazolopyrimidine, pyridazinone, pyridine ordiazolohexahydroquinoline derivatives which bind to the erythropoietin receptor modulatin the domain of the recptor; bioassay |
05/02/2006 | US7037898 Tumor-activated prodrug compounds and treatment |
05/02/2006 | US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives |
05/02/2006 | US7037709 Comprises nucleotide sequences coding microsomal enzymes for detoxification of xenobiotic compounds in liver; drug screening; gene therapy |
05/02/2006 | US7037702 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents |
05/02/2006 | US7037701 Genetic engineering; detection moderators of kinase peptidespeptides |
05/02/2006 | US7037668 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
05/02/2006 | US7037666 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction |
05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |